Afra Anjum, Leo Nicolai, Rainer Kaiser/LinkedIn
Sep 14, 2025, 23:06
Platelet Heterogeneity In Disease: The Many and The Diverse?
Leo Nicolai, Head of Junior Research Group and Clinician Scientist at LMU Medical Center Munich, shared on LinkedIn:
”Happy to see our invited review in Blood written by Rainer Kaiser, Afra Anjum and myself now online, hope you enjoy the read
Complicated and controversial topic, happy to discuss and lets see what the next years of science show!”
Read the full review in Blood.
Article: Platelet heterogeneity in disease: the many and the diverse?
Authors: Rainer Kaiser, Afra Anjum, Leo Nicolai
Stay updated on all scientific advances in the field of platelet disorders with Hemostasis Today.
-
Feb 23, 2026, 14:45Stacey McGeown: Rare Disease Awareness Day at QUB Marks the Start of Rare Disease Month
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy